Reason for Recall: The AED instructs the responder, by voice prompts, to press the shock button. However, the shock button is covered and is not visible. Therefore, the responder is not able to provide therapy (shock).
Class I Medical Device Recall: Physio Control, Inc. LifePak CR Plus Automated External Defibrillators (AEDs)
Summary Information for: COBAS® TaqMan® HBV Test For Use With the High Pure System
Summary Information for: COBAS® TaqMan® HBV Test For Use With the High Pure System
Federal Register: Public Advisory Panels or Committees: Request for Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives
The FDA is requesting that any industry organization interested in participating in the selection of nonvoting industry representatives to serve on the Devices Good Manufacturing Practice Advisory Committee (DGMPAC) and certain device panels of the…
Federal Register: Public Advisory Panels or Committees: Request for Industry Organizations Interested in Participating in Selection Process for Nonvoting Industry Representatives
The FDA is requesting that any industry organization interested in participating in the selection of nonvoting industry representatives to serve on the Devices Good Manufacturing Practice Advisory Committee (DGMPAC) and certain device panels of the…
Federal Register: General and Plastic Surgery Devices: Reclassification of the Absorbable Hemostatic Device; Reopening of Comment Period
The FDA is is reopening until October 14, 2008, the comment period for a proposed rule published in the Federal Register to reclassify the absorbable hemostatic device from class III (premarket approval) into class II (special controls).
Federal Register: General and Plastic Surgery Devices: Reclassification of the Absorbable Hemostatic Device; Reopening of Comment Period
The FDA is is reopening until October 14, 2008, the comment period for a proposed rule published in the Federal Register to reclassify the absorbable hemostatic device from class III (premarket approval) into class II (special controls).
Federal Register: Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Draft Guidance for Industry and Food and Drug Administration Staff; Reopening of Comment Period
The draft guidance describes a means by which the absorbable hemostatic device may comply with the requirements of special controls if it is reclassified. FDA is reopening the comment period to update comments and to receive any new information.
Federal Register: Class II Special Controls Guidance Document: Absorbable Hemostatic Device; Draft Guidance for Industry and Food and Drug Administration Staff; Reopening of Comment Period
The draft guidance describes a means by which the absorbable hemostatic device may comply with the requirements of special controls if it is reclassified. FDA is reopening the comment period to update comments and to receive any new information.
FDA Workshop: Best Practices For Pacemaker and ICD Lead Postmarket Surveillance, October 2-3, 2008 (Final Agenda Now Available)
Meeting announcement for FDA Workshop: Best Practices For Pacemaker and ICD Lead Postmarket Surveillance, October 2-3, 2008.
Schering-Plough launches Bridion (sugammadex) in Europe
Schering-Plough Corporation has announced that the European launch of Bridion (sugammadex) injection has begun with its introduction this week in Sweden, and that the product is expected to be available soon in the United Kingdom and Germany, with several other European markets to follow by the end of the year and in early 2009.
Social Network
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Aug | Oct » | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | |||||
Recent Entries
- Wegmans Food Markets To Offer No-Cost Generic Antibiotics Through March
- CMS Finalizes Medicare Rule That Aims To Stop Pharmacy Benefit Manager Practice That Inflates Drug Costs For Some Beneficiaries
- ExCell Study Joined By Children’s Memorial Hospital, Chicago
- Participants To Interact Online With US FDA In Process Validation Webinar
- Manhattan Research Releases Top New Year’s Resolutions For Pharma Brand Managers
- NIH Grants Phylonix Phase II SBIR To Develop High-Throughput In Vivo Zebrafish Assays
- Circassia Completes Patient Recruitment For Phase II Clinical Trial Of Toleromune(R) Allergy Treatment
- ImQuest Submits Investigational New Product Application To The Food And Drug Administration To Initiate HIV Therapeutic Clinical Trials With IQP-0410
- FDA Issues A Complete Response Letter For Lilly’s Olanzapine LAI For Treatment Of Schizophrenia In Adults
- Kaunitz on Women’s Health: A Safer Approach to Prescribing Menopausal Estrogen
Recent Comments
- Keine Kommentare vorhanden.
Translators
Categories
- Addictions
- Alcohol Abuse
- Complementary and Alternative Medicine
- Drug Approvals
- Drug Evaluation and Research
- Drug Shortages
- Drugs and Food Information
- Food and Nutrition Information
- Health Information
- Illegal Drugs
- Medical Devices
- Medical Devices and Radiological Health
- Pharmaceutical Industry News
- Pharmacist News
- Safety Information
- Uncategorized
Archives
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- April 2007
- March 2007
- February 2007
- January 2007
- December 2006
- November 2006
- October 2006
- September 2006
- August 2006
- July 2006
- June 2006
- May 2006
- April 2006
- March 2006
- February 2006
- January 2006
- December 1969
Pages
Blogroll
- Alcohol / Addiction / Illegal Drugs News From Medical News Today - Latest Alcohol / Addiction / Illegal Drugs News From Medical News Today.
- Alcohol and Alcoholism - current issue - Alcohol and Alcoholism - RSS feed of current issue